Drugs for the Heart

0.0

The new edition of this market-leading cardiac drug resource equips you with the latest advances in cardiovascular pharmacology, one of the most rapidly changing areas of medicine. It not only offers in-depth information on all of the drug classes used to treat heart disease, but also covers new drug classes, drug use for single and multiple problem management, and more. Dynamic full-color drawings illustrate key pharmacological and physiological actions, and a user-friendly organization directs you to the information you need. An increased emphasis on thepractical use of drugs saves you valuable time in researching relevant information. Key Features Features the practice-proven experience of two well-known editors who represent the best possible combination of clinical and research expertise in cardiovascular therapeutics. Offers easy-to-access, useful information on when to use each drug—and for what conditions—in a chapter entitled “Which Drug for Which Disease.” Discusses the management of single diseases and multiple comorbidities. Summarizes each drug class at the end of chapters to expedite reference.

0.0

Lionel H. Opie MD, DPhiL, DSc, FRCP, Codirector, Cape Heart Centre annd Medical Research Councill's Interuniversity Heart Research Group; Professor of Medicine, University of Cape Town Medical School, Cape Town, South Africa; Visiting Professor, 1984-1998, Division of Cardiovascular Medicine, Stanford University Medical Center, Stanford, CA. Bernard J. Gersh, MB, ChB, DPhil, FACC, Professor of Medicine and Chair, Cardiovascular Education, Mayo Medical School; Consultant, Cardiovascular Diseases and Internal Medicine, Mayo Clinic, Rochester, MN. Table of Contents ß- Blocking Agents Nitrates and Newer Antianginals Calcium Channel Blockers Diuretics Inhibitors of Angiotensin-Converting Enzyme, Angiotensin II Receptor, Aldosterone, and Renin Acute nad Chronic Heart Failure: Positive Inotropes, Vasodilators, and Digoxin Antihypertensive Drugs Antiarrhythmic Drugs and Strategies Antithrombotic Agents: Platelet Inhibitors, Anticoagulants, and Fibrinolytics Lipid-Modifying and Antiatherosclerotic Drugs Metabolic Syndrome, Hyperglycemia, and Type 2 Diabetes Which Therapy for Which Condition? Index